We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.
all report title image

U.S. INTRAVENOUS IMMUNOGLOBULIN MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2021 - 2028)

U.S. Intravenous Immunoglobulin Market, by Formulation (Liquid and Powder), by Application (Hypogammaglobulinemia, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Primary Immunodeficiency Diseases, Myasthenia Gravis, Multifocal Motor Neuropathy, Kawasaki Disease, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

  • Published In: 22 Dec, 2021
  • Code: CMI4829
  • Page number: 210
  • Formats:   Excel and PDF
  • Industry: Pharmaceutical
Ingographics Image

Table of Contents (Version-2026)

  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Overview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Formulation
      • Market Snippet, By Application
      • Market Snippet, By Distribution Channel
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Porter’s Analysis
    • Industry Trends
    • Key Highlights
    • Epidemiology
    • Reimbursement Scenario
    • Regulatory Scenario
    • Product Launch and Approvals
    • Acquisition and Collaboration Scenario
  4. U.S. Intravenous Immunoglobulin Market - Impact of Coronavirus (Covid-19) Pandemic

    • COVID-19 Epidemiology
    • Impact of COVID-19 on Demand and Supply of Intravenous Immunoglobulin
    • Impact of COVID-19 on the overall Healthcare Sector
  5. U.S. Intravenous Immunoglobulin Market, By Formulation, 2017 - 2028 (US$ Billion)

    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018 - 2028
      • Segment Trends
    • Liquid
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Billion)
    • Powder
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Billion)
  6. U.S. Intravenous Immunoglobulin Market, By Application, 2017 - 2028 (US$ Billion)

    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018 - 2028
      • Segment Trends
    • Hypogammaglobulinemia
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Billion)
    • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Billion)
    • Primary Immunodeficiency Diseases
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Billion)
    • Myasthenia Gravis
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Billion)
    • Multifocal Motor Neuropathy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Billion)
    • Kawasaki Disease
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Billion)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Billion)
  7. U.S. Intravenous Immunoglobulin Market, By Distribution Channel, 2017 - 2028 (US$ Billion)

    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018 - 2028
      • Segment Trends
    • Hospital Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Billion)
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Billion)
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Billion)
  8. Competitive Landscape

    • Company Profiles
      • Biotest AG *
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Octapharma AG
      • Grifols S.A.
      • Kedrion Biopharma, Inc.
      • CSL Behring
      • McKesson Corporation
      • Takeda Pharmaceutical Company Limited
      • Bio Products Laboratory Ltd.
      • Pfizer, Inc.
      • ADMA Biologics, Inc. 

*Key pointers provided are also applicable to other companies covered in the scope of the report.

  1. Section

    • Research Methodology
    • About us
    • Contact

*Browse 33 market data tables and 25 figures on “Intravenous Immunoglobulin Market” – U.S. Forecast to 2028.

  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
Logo

Credibility and Certifications

DUNS Registered

860519526

ESOMAR
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

Clutch
Credibility and Certification

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2026 Coherent Market Insights Pvt Ltd. All Rights Reserved.